Search Results - "Kasprzyk, Philip G"

Refine Results
  1. 1

    In Vitro Evaluation of the Potential for Drug Interactions by Salidroside by Kasprzyk, Philip G., Tremaine, Larry, Fahmi, Odette A., Weng, Jing-Ke

    Published in Nutrients (25-08-2023)
    “…Several studies utilizing Rhodiola rosea, which contains a complex mixture of phytochemicals, reported some positive drug-drug interaction (DDI) findings based…”
    Get full text
    Journal Article
  2. 2

    Safety of a Sustainably Produced, Bioengineered, Nature-Identical Salidroside Compound by Kasprzyk, Philip G, Vickery, Christopher, Ye, Mingli, Sewastianik, Magdalena, Gong, Wei, Ding, Sheng, Dziwenka, Margitta, Mozingo, Amy, Valm, Kaiti, Schachner, Holly, Weng, Jing-Ke

    Published in Nutrients (01-06-2022)
    “…Bioactive phytochemicals such as salidroside have been studied to understand the beneficial effects of , an herbaceous plant used in traditional medicine to…”
    Get full text
    Journal Article
  3. 3

    STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice by Meyer-Losic, Florence, Newman, Simon P, Day, Joanna M, Reed, Michael J, Kasprzyk, Philip G, Purohit, Atul, Foster, Paul A

    Published in PloS one (06-12-2013)
    “…Despite paclitxael's clinical success, treating hormone-refractory breast cancer remains challenging. Paclitaxel has a poor pharmacological profile,…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases by Brezak, Marie-Christine, Quaranta, Muriel, Contour-Galcera, Marie-Odile, Lavergne, Olivier, Mondesert, Odile, Auvray, Pierrïck, Kasprzyk, Philip G, Prevost, Gregoire P, Ducommun, Bernard

    Published in Molecular cancer therapeutics (01-09-2005)
    “…Cell cycle regulators, such as the CDC25 phosphatases, are potential targets for the development of new anticancer drugs. Here we report the identification and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    3,17-Disubstituted 2-Alkylestra-1,3,5(10)-trien-3-ol Derivatives:  Synthesis, In Vitro and In Vivo Anticancer Activity by Bubert, Christian, Leese, Mathew P, Mahon, Mary F, Ferrandis, Eric, Regis-Lydi, Sandra, Kasprzyk, Philip G, Newman, Simon P, Ho, Yaik T, Purohit, Atul, Reed, Michael J, Potter, Barry V. L

    Published in Journal of medicinal chemistry (06-09-2007)
    “…Estradiol-3,17-O,O-bis-sulfamates inhibit steroid sulfatase (STS), carbonic anhydrase (CA), and, when substituted at C-2, cancer cell proliferation and…”
    Get full text
    Journal Article
  9. 9

    Tetrahydroisoquinolinone-Based Steroidomimetic and Chimeric Microtubule Disruptors by Leese, Mathew P., Jourdan, Fabrice L., Major, Meriel R., Dohle, Wolfgang, Hamel, Ernest, Ferrandis, Eric, Fiore, Ann, Kasprzyk, Philip G., Potter, Barry V. L.

    Published in ChemMedChem (01-01-2014)
    “…A structure–activity relationship (SAR) translation strategy was used for the discovery of tetrahydroisoquinoline (THIQ)‐based steroidomimetic and chimeric…”
    Get full text
    Journal Article
  10. 10

    Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1-Substituted Tetrahydroisoquinolines by Dohle, Wolfgang, Leese, Mathew P., Jourdan, Fabrice L., Major, Meriel R., Bai, Ruoli, Hamel, Ernest, Ferrandis, Eric, Kasprzyk, Philip G., Fiore, Ann, Newman, Simon P., Purohit, Atul, Potter, Barry V. L.

    Published in ChemMedChem (01-02-2014)
    “…The syntheses and antiproliferative activities of novel substituted tetrahydroisoquinoline derivatives and their sulfamates are discussed. Biasing of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minerval by Martínez, Jordi, Vögler, Oliver, Casas, Jesús, Barceló, Francisca, Alemany, Regina, Prades, Jesús, Nagy, Tünde, Baamonde, Carmela, Kasprzyk, Philip G, Terés, Silvia, Saus, Carlos, Escribá, Pablo V

    Published in Molecular pharmacology (01-02-2005)
    “…Most drugs currently used for human therapy interact with proteins, altering their activity to modulate the pathological cell physiology. In contrast,…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Cover Picture: Tetrahydroisoquinolinone-Based Steroidomimetic and Chimeric Microtubule Disruptors (ChemMedChem 1/2014) by Leese, Mathew P., Jourdan, Fabrice L., Major, Meriel R., Dohle, Wolfgang, Hamel, Ernest, Ferrandis, Eric, Fiore, Ann, Kasprzyk, Philip G., Potter, Barry V. L.

    Published in ChemMedChem (01-01-2014)
    “…A structure-activity relationship (SAR) translation strategy was used for the discovery of tetrahydroisoquinoline (THIQ)-based steroidomimetic and chimeric…”
    Get full text
    Journal Article
  15. 15

    2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique by Foster, Paul A., Ho, Yaik T., Newman, Simon P., Kasprzyk, Philip G., Leese, Mathew P., Potter, Barry V. L., Reed, Michael J., Purohit, Atul

    Published in Breast cancer research and treatment (01-09-2008)
    “…Breast cancer is the leading cause of cancer deaths among women worldwide. The theory of targeting both cancer cells directly and their blood supply has…”
    Get full text
    Journal Article
  16. 16

    A novel synthetic inhibitor of CDC25 phosphatases: BN82002 by BREZAK, Marie-Christine, QUARANTA, Muriel, LANCO, Christophe, KASPRZYK, Philip G, PREVOST, Gregoire P, DUCOMMUN, Bernard, MONDESERT, Odile, GALCERA, Marie-Odile, LAVERGNE, Olivier, ALBY, Frédéric, CAZALES, Martine, BALDIN, Véronique, THURIEAU, Christophe, HARNETT, Jeremiath

    Published in Cancer research (Chicago, Ill.) (01-05-2004)
    “…CDC25 dual-specificity phosphatases are essential regulators that dephosphorylate and activate cyclin-dependent kinase/cyclin complexes at key transitions of…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    IIn Vitro/I Evaluation of the Potential for Drug Interactions by Salidroside by Kasprzyk, Philip G, Tremaine, Larry, Fahmi, Odette A, Weng, Jing-Ke

    Published in Nutrients (01-08-2023)
    “…Several studies utilizing Rhodiola rosea, which contains a complex mixture of phytochemicals, reported some positive drug-drug interaction (DDI) findings based…”
    Get full text
    Journal Article
  20. 20

    Recombinant Anti-ErbB2 Immunotoxins Containing Pseudomonas Exotoxin by Batra, Janendra K., Kasprzyk, Philip G., Bird, Robert E., Pastan, Ira, King, C. Richter

    “…Immunotoxins were made using five different murine monoclonal antibodies to the human erbB2 gene product and LysPE40, a 40-kDa recombinant form of Pseudomonas…”
    Get full text
    Journal Article